Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Baseline characteristics of SARS-CoV-2 vaccine non-responders in a large population-based sample.
Yaseen A, DeSantis SM, Sabharwal R, Talebi Y, Swartz MD, Zhang S, Leon Novelo L, Pinzon-Gomez CL, Messiah SE, Valerio-Shewmaker M, Kohl HW 3rd, Ross J, Lakey D, Shuford JA, Pont SJ, Boerwinkle E. Yaseen A, et al. Among authors: pinzon gomez cl. PLoS One. 2024 May 13;19(5):e0303420. doi: 10.1371/journal.pone.0303420. eCollection 2024. PLoS One. 2024. PMID: 38739625 Free PMC article.
RE: Incidence of SARS-CoV-2 Breakthrough Infections After Vaccination in Adults: A Population-Based Survey Through 1 March 2023.
DeSantis SM, Yaseen A, Hao T, León-Novelo L, Talebi Y, Valerio-Shewmaker MA, Pinzon Gomez CL, Messiah SE, Kohl HW 3rd, Kelder SH, Ross JA, Padilla LN, Silberman M, Wylie S, Lakey D, Shuford JA, Pont SJ, Boerwinkle E, Swartz MD. DeSantis SM, et al. Among authors: pinzon gomez cl. Open Forum Infect Dis. 2023 Nov 29;10(12):ofad564. doi: 10.1093/ofid/ofad564. eCollection 2023 Dec. Open Forum Infect Dis. 2023. PMID: 38099238 Free PMC article. No abstract available.
Incidence and Predictors of Breakthrough and Severe Breakthrough Infections of SARS-CoV-2 After Primary Series Vaccination in Adults: A Population-Based Survey of 22 575 Participants.
DeSantis SM, Yaseen A, Hao T, León-Novelo L, Talebi Y, Valerio-Shewmaker MA, Pinzon Gomez CL, Messiah SE, Kohl HW, Kelder SH, Ross JA, Padilla LN, Silberman M, Tuzo S, Lakey D, Shuford JA, Pont SJ, Boerwinkle E, Swartz MD. DeSantis SM, et al. Among authors: pinzon gomez cl. J Infect Dis. 2023 May 12;227(10):1164-1172. doi: 10.1093/infdis/jiad020. J Infect Dis. 2023. PMID: 36729177
Antibody Duration After Infection From SARS-CoV-2 in the Texas Coronavirus Antibody Response Survey.
Swartz MD, DeSantis SM, Yaseen A, Brito FA, Valerio-Shewmaker MA, Messiah SE, Leon-Novelo LG, Kohl HW, Pinzon-Gomez CL, Hao T, Zhang S, Talebi Y, Yoo J, Ross JR, Gonzalez MO, Wu L, Kelder SH, Silberman M, Tuzo S, Pont SJ, Shuford JA, Lakey D, Boerwinkle E. Swartz MD, et al. Among authors: pinzon gomez cl. J Infect Dis. 2023 Jan 11;227(2):193-201. doi: 10.1093/infdis/jiac167. J Infect Dis. 2023. PMID: 35514141 Free PMC article.